Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SyB L-0501 in Relapsed/Refractory Multiple Myeloma
NCT01849848Phase 2Completed
- Sponsor
- SymBio Pharmaceuticals
- Start
- Nov 2011
- Primary completion
- Jul 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bendamustine in multiple myeloma (MM), sponsored by SymBio Pharmaceuticals. Started Nov 2011; status: completed.
02
Drugs
bendamustine
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT01849848.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01849848.